Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review …

H Imran, IM Tleyjeh, A Zirakzadeh… - Bone marrow …, 2006 - nature.com
… of anticoagulation in the prevention of veno-occlusive disease. … between anticoagulation and
hepatic veno-occlusive disease… nonsignificant beneficial effect of anticoagulation. However, …

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see …

M Attal, F Huguet, H Rubie, A Huynh, JP Charlet… - 1992 - ashpublications.org
… endothelial injury, it was reasonable to speculate that prophylactic anticoagulant therapy
might preserve venous outflow, and ultimately hepatic function. Two reports of uncontrolled …

Interventions for prophylaxis of hepatic venoocclusive disease in people undergoing haematopoietic stem cell transplantation

DKL Cheuk, AKS Chiang, SY Ha… - Cochrane Database of …, 2015 - cochranelibrary.com
… Heparin is an anticoagulant which enhances the action of the natural anticoagulant
antithrombin in inhibiting multiple coagulation factors including thrombin, factors VIIa, IXa, Xa, XIa, …

[HTML][HTML] Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment

JH Dalle, SA Giralt - Biology of Blood and Marrow Transplantation, 2016 - Elsevier
… Moreover, some studies have support the use of prophylaxis … Additionally, options for
prophylaxis in individuals who are at … treated, early therapy and prophylaxis may be appropriate …

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an …

M Mohty, F Malard, M Abecasis, E Aerts… - Bone marrow …, 2020 - nature.com
Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a
potentially life-threatening complication that can develop after hematopoietic cell …

Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.

J Rosenthal, L Sender, R Secola, R Killen… - Bone marrow …, 1996 - europepmc.org
Veno-occlusive disease (VOD) of the liver is an early … The role of anticoagulants for the
prevention of VOD is … can be safely used prophylactically in children undergoing myeloablative …

Prophylactic heparin does not prevent liver venoocclusive disease following autologous bone marrow transplantation

L Marsa‐Vila, NC Gorin, JP Laporte… - European journal of …, 1991 - Wiley Online Library
Prophylactic heparin does not prevent liver venoâ•’occlusive disease following autologous
bone marrow transplantation Page 1 Prophylactic heparin does not prevent liver veno-…

[HTML][HTML] Veno occlusive disease: update on clinical management

M Senzolo, G Germani, E Cholongitas… - World journal of …, 2007 - ncbi.nlm.nih.gov
Prophylactic administration of ursodeoxycholic acid, being an … to promote fibrinolysis with
or without anticoagulation[49-51]. … Thus, administration of pro-fibrinolytics and anticoagulants

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

DL Forrest, K Thompson, VG Dorcas… - Bone marrow …, 2003 - nature.com
… None of the bleeding episodes, including the three that were ⩾grade II, were considered
severe enough to contraindicate further anticoagulant prophylaxis for VOD and dalteparin …

Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease

E Peres, P Kintzel, R Dansey, R Baynes… - Blood coagulation & …, 2008 - journals.lww.com
… state and a localized consumption of the natural anticoagulants, antithrombin III, protein C
and … Treatment was primarily directed at early intervention rather than prophylactic therapy to …